CM Life Sciences III Inc. Unit
CMLTU
CMLTU was delisted on the 17th of December, 2021.
28 hedge funds and large institutions have $127M invested in CM Life Sciences III Inc. Unit in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 33 closing their positions.
51% less funds holding
Funds holding: 57 → 28 (-29)
56% less capital invested
Capital invested by funds: $291M → $127M (-$164M)
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
88% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 33
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMH
Apollo Management Holdings
New York
|
+$7.19M |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$3.84M |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
+$3.75M |
| 4 |
JP Morgan Chase
New York
|
+$390K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$265K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TOMS Capital Investment Management
New York
|
-$23.8M |
| 2 |
TP
Third Point
New York
|
-$14.2M |
| 3 |
D.E. Shaw & Co
New York
|
-$13.7M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$13.7M |
| 5 |
IM
Islet Management
New York
|
-$10.9M |
CMLTU Hedge Fund Activity: Q3 2021 in Review
28 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences III Inc. Unit (CMLTU) for Q3 2021, worth a combined $127M — down 56% from $291M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of CMLTU and 4 opened new positions — a net loss of 29 holders — while 12 trimmed existing stakes and 2 added.
The largest buyer was Apollo Management Holdings, opening a new position worth an estimated $7.19M. The largest seller was TOMS Capital Investment Management, exiting entirely with an estimated $23.8M sold.
- 28 institutional investors held CM Life Sciences III Inc. Unit (CMLTU) as of Q3 2021, down from 57 in Q2 2021.
- Funds reported $127M of CM Life Sciences III Inc. Unit stock for Q3 2021, down 56% quarter-over-quarter.
- 4 funds opened new CM Life Sciences III Inc. Unit positions in Q3 2021 and 33 closed out, a net change of -29 holders.
- The largest CM Life Sciences III Inc. Unit buyer in Q3 2021 was Apollo Management Holdings, an estimated $7.19M added.
- The largest CM Life Sciences III Inc. Unit seller in Q3 2021 was TOMS Capital Investment Management, an estimated $23.8M sold.
Based on aggregated 13F filings for Q3 2021.